Lab Automation In Drug Discovery Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the lab automation in drug discovery market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Lab Automation In Drug Discovery Market Now And By 2029?

The lab automation in drug discovery market has experienced consistent growth in recent years. Its expansion is projected from $6.47 billion in 2024 to reach $6.77 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 4.7%. Historically, this growth can be ascribed to factors such as the increasing intricacy of drug discovery processes, the imperative for enhanced efficiency and reduced costs, the expanding requirement for high-throughput screening, escalating labor expenses, and the urgency to expedite drug development schedules.

The lab automation in drug discovery market size is set for significant expansion over the next few years, projected to reach $8.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. This growth throughout the forecast period stems from factors such as the broadening drug pipelines of pharmaceutical companies, an increase in personalized medicine and precision therapeutics, a heightened focus on rare diseases and orphan drugs, the demand for remote and decentralized clinical trials, and the advancement of microfluidics and lab-on-a-chip technologies. Notable trends during this period encompass the widespread availability of modular and customizable automation solutions, the integration of cloud-based platforms for data management and collaboration, the spread of automation in developing markets, the emergence of virtual drug discovery companies utilizing automation and digital solutions, and the establishment of standardized protocols and interoperable systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Which Long-Term Drivers Are Expected To Sustain The Lab Automation In Drug Discovery Market?

The rising need for precision medicine is projected to boost the expansion of lab automation within the drug discovery market in the future. This medical strategy, also termed personalized medicine, focuses on treatment and prevention by considering each individual’s unique genetic makeup, environmental factors, and lifestyle. By enhancing research speed, boosting experimental reproducibility, and optimizing the effectiveness of precision medicine and drug discovery processes, lab automation ultimately contributes to developing better medicines and diagnostics tailored for individual patients. For example, data from October 2022, released by the Personalized Medicine Coalition (PMC), a US-based organization dedicated to advancing the comprehension and implementation of personalized medicine, indicated that over 75,000 genetic testing products and 300 personalized medicines would be available in the market to address multiple types of cancer, genetic rare diseases, and various chronic and infectious diseases. Consequently, the growing requirement for precision medicine is fueling the growth of lab automation within the drug discovery market.

How Is The Lab Automation In Drug Discovery Market Classified By Different Segments?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Current And Upcoming Trends Are Shaping The Lab Automation In Drug Discovery Market?

Major companies operating in lab automation in the drug discovery market are increasingly focusing on developing sophisticated solutions, such as rapid idea-to-data solutions, to gain a competitive advantage. A rapid idea-to-data solution refers to an optimized process or platform that allows individuals or organizations to quickly transform their ideas or concepts into actionable insights or data-driven results. For instance, in April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. This is a lab automation tool specifically designed for small-molecule discovery in drug development. The on-demand, scalable Strateos Cloud Lab Automation-as-a-Service Platform incorporates linked robotic automation with 23 workcells and hundreds of instruments. The platform facilitates early lead generation through lead optimization, orchestrated by a software architecture that allows users to design compounds of interest in the cloud and have them automatically assembled and tested using a variety of methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

Who Are The Primary Market Leaders In The Lab Automation In Drug Discovery Market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2025, By The Business Research Company

Robotics And Automation Actuators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/robotics-and-automation-actuators-global-market-report

Automation As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-as-a-service-global-market-report

Automation Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automation-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795